Track record
David Charles Lubner
An officer, director or large holder of 2 blank-check companies. Every role below was declared by David Charles Lubner in an SEC ownership filing.
Vehicles
2
Still live
0
Closed a deal
2 of 2
Capital involved
$256M
Every vehicle, newest first
- Disc Medicine, Inc.IRON · Director · IPO Aug 13, 2020$121MCompleted
- POINT Biopharma Global Inc.— · Director · IPO Jul 9, 2020$136MCompleted
Compiled from Forms 3 and 3/A filed with the SEC under CIK 1572000. Roles are as declared at the time of filing and may have changed since. Nothing here is a judgement about any individual.